Pub Date : 2023-11-07DOI: 10.33667/2078-5631-2023-23-24-29
T. Yu. Agafonova, N. N. Elovikova, A. N. Fadeeva, D. A. Igisheva, V. O. Reshetnyak, A. A. Yudina
Background. It is of interest to study in detail the consequences of COVID-19 in women, since there is evidence that female sex is a risk factor for post-COVID syndrome. The aim of the study. To study the subjective and laboratory manifestations of post-COVID syndrome in women depending on age and results for SARS-CoV-2. Materials and methods. One-time retrospective analysis of 281 medical records of women aged 20 to 91 was performed; WHO age groups are divided into test and control subgroups (confirmed and unconfirmed COVID-19, respectively). The questionnaire for post-covid syndrome, biochemical and clinical blood tests were evaluated. Statistical analysis was done using the Mann-Whitney test, Pearson’s χ 2 , analysis of variance, Spearman’s correlation. Results. Women with proven COVID-19 were 1.5–2.0 times more likely to report a decrease in quality of life, exercise tolerance, cough, cardiac symptoms, edema, hair loss, skin rash, arthralgia. Laboratory-proven COVID-19 is associated with the severity of COVID-19, most of the above symptoms, increased ESR. The test subgroup of young women had higher ALT levels. In the test subgroup of middle age, a decrease in the quality of life and working capacity, hair loss and skin rash were 1.5 times more common. In the test subgroup of the elderly, diabetes mellitus was detected 2 times more often, and lower platelet counts were observed. Old women of the test subgroup have higher ESR, D-dimer and lower hemoglobin. Conclusions. The severity of post-COVID syndrome in women depends on the severity and laboratory confirmation of the transferred COVID-19, in contrast to the duration of its subjective manifestations. The greatest decrease in the quality of life after a significantly transferred COVID-19 is observed in middle-aged women. The control of laboratory parameters in post-covid syndrome in women should be differentiated depending on age.
{"title":"Post-covid syndrome in women of different ages with laboratory-proven and non-confirmed COVID-19","authors":"T. Yu. Agafonova, N. N. Elovikova, A. N. Fadeeva, D. A. Igisheva, V. O. Reshetnyak, A. A. Yudina","doi":"10.33667/2078-5631-2023-23-24-29","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-23-24-29","url":null,"abstract":"Background. It is of interest to study in detail the consequences of COVID-19 in women, since there is evidence that female sex is a risk factor for post-COVID syndrome. The aim of the study. To study the subjective and laboratory manifestations of post-COVID syndrome in women depending on age and results for SARS-CoV-2. Materials and methods. One-time retrospective analysis of 281 medical records of women aged 20 to 91 was performed; WHO age groups are divided into test and control subgroups (confirmed and unconfirmed COVID-19, respectively). The questionnaire for post-covid syndrome, biochemical and clinical blood tests were evaluated. Statistical analysis was done using the Mann-Whitney test, Pearson’s χ 2 , analysis of variance, Spearman’s correlation. Results. Women with proven COVID-19 were 1.5–2.0 times more likely to report a decrease in quality of life, exercise tolerance, cough, cardiac symptoms, edema, hair loss, skin rash, arthralgia. Laboratory-proven COVID-19 is associated with the severity of COVID-19, most of the above symptoms, increased ESR. The test subgroup of young women had higher ALT levels. In the test subgroup of middle age, a decrease in the quality of life and working capacity, hair loss and skin rash were 1.5 times more common. In the test subgroup of the elderly, diabetes mellitus was detected 2 times more often, and lower platelet counts were observed. Old women of the test subgroup have higher ESR, D-dimer and lower hemoglobin. Conclusions. The severity of post-COVID syndrome in women depends on the severity and laboratory confirmation of the transferred COVID-19, in contrast to the duration of its subjective manifestations. The greatest decrease in the quality of life after a significantly transferred COVID-19 is observed in middle-aged women. The control of laboratory parameters in post-covid syndrome in women should be differentiated depending on age.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"73 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-39-43
V. L. Kozlovskii, D. N. Kosterin, O. V. Lepik, M. Yu. Popov
Comparison of the development of chemically induced seizures in the experiment with the change in convulsive thresholds during electroconvulsive therapy (ECT) has demonstrated that repeated ‘chemical’ seizures can initiate the development of the kindling phenomenon, but regular ECT from the first to the 14th session most likely cause an increase in convulsive thresholds. However, the repeated ECT over 15 sessions is associated with a rapid decrease in the threshold current dose and probable dysregulation of endogenous anticonvulsant mechanisms, with the risk of the development of uncontrolled paroxysmal conditions and the risk of organic CNS lesions. The mechanisms of the convulsive action of ECT and pentylenetetrazolinduced kindling are fundamentally different. Differences in the pathogenesis of systemic convulsive reactions determine the divergent change in seizure thresholds during ECT and pentylenetetrazol stimulations.
{"title":"Specificity of seizure genesis during electroconvulsive therapy and modified pentylenetetrazole kindling","authors":"V. L. Kozlovskii, D. N. Kosterin, O. V. Lepik, M. Yu. Popov","doi":"10.33667/2078-5631-2023-21-39-43","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-39-43","url":null,"abstract":"Comparison of the development of chemically induced seizures in the experiment with the change in convulsive thresholds during electroconvulsive therapy (ECT) has demonstrated that repeated ‘chemical’ seizures can initiate the development of the kindling phenomenon, but regular ECT from the first to the 14th session most likely cause an increase in convulsive thresholds. However, the repeated ECT over 15 sessions is associated with a rapid decrease in the threshold current dose and probable dysregulation of endogenous anticonvulsant mechanisms, with the risk of the development of uncontrolled paroxysmal conditions and the risk of organic CNS lesions. The mechanisms of the convulsive action of ECT and pentylenetetrazolinduced kindling are fundamentally different. Differences in the pathogenesis of systemic convulsive reactions determine the divergent change in seizure thresholds during ECT and pentylenetetrazol stimulations.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"39 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135680084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-7-12
L. V. Chichanovskaya, T. A. Slyusar, Yu. V. Abramenko, T. M. Nekrasova, I. N. Slyusar
Objective . To study influence of Mexidol® and Mexidol® FORTE 250 on cognitive status of patients with post-COVID syndrome. Material and methods . We examined 112 patients aged 24–60 years (55 men and 57 women) who were divided into tho groups. The main group consisted of 76 patients with confirmed SARS-CoV‑2 NEW coronavirus infection having symptoms that served as the basis for the diagnosis of post-COVID syndrome. The control group consisted of 36 people who were not ill with coronavirus infection. Patients underwent neurological and general somatic examination. To study cognitive functions, we used the Mini Mental State Examination (MMSE) and the Frontal Assessment Batter (FAB). Memory was evaluated according to results of ‘the Memory’ subtest of the MMSE, the 10-word test and tests of visual memory. The level of attention was studied using the Schulte tables and the word fluency test; visual-spatial functions were evaluated using the clock-drawing test. To correct the identified disorders, Mexidol® was used according to the scheme: 500 mg once daily intravenously for 14 days, followed by Mexidol® FORTE 250 750 mg per day orally (250 mg three times a day) for 2 months. Results . Patients with post-COVID syndrome were characterized by cognitive heterogeneity: mild and moderate cognitive impairments prevailed in the structure of cognitive disorders. The course of treatment with Mexidol® led to decrease in the severity of cognitive symptoms of post-COVID syndrome. The high efficacy and safety of long-term sequential therapy with Mexidol® (injections followed by tablets of Mexidol® FORTE 250) have been shown.
{"title":"Pharmacological correction of cognitive status of patients with post-COVID syndrome","authors":"L. V. Chichanovskaya, T. A. Slyusar, Yu. V. Abramenko, T. M. Nekrasova, I. N. Slyusar","doi":"10.33667/2078-5631-2023-21-7-12","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-7-12","url":null,"abstract":"Objective . To study influence of Mexidol® and Mexidol® FORTE 250 on cognitive status of patients with post-COVID syndrome. Material and methods . We examined 112 patients aged 24–60 years (55 men and 57 women) who were divided into tho groups. The main group consisted of 76 patients with confirmed SARS-CoV‑2 NEW coronavirus infection having symptoms that served as the basis for the diagnosis of post-COVID syndrome. The control group consisted of 36 people who were not ill with coronavirus infection. Patients underwent neurological and general somatic examination. To study cognitive functions, we used the Mini Mental State Examination (MMSE) and the Frontal Assessment Batter (FAB). Memory was evaluated according to results of ‘the Memory’ subtest of the MMSE, the 10-word test and tests of visual memory. The level of attention was studied using the Schulte tables and the word fluency test; visual-spatial functions were evaluated using the clock-drawing test. To correct the identified disorders, Mexidol® was used according to the scheme: 500 mg once daily intravenously for 14 days, followed by Mexidol® FORTE 250 750 mg per day orally (250 mg three times a day) for 2 months. Results . Patients with post-COVID syndrome were characterized by cognitive heterogeneity: mild and moderate cognitive impairments prevailed in the structure of cognitive disorders. The course of treatment with Mexidol® led to decrease in the severity of cognitive symptoms of post-COVID syndrome. The high efficacy and safety of long-term sequential therapy with Mexidol® (injections followed by tablets of Mexidol® FORTE 250) have been shown.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"25 12","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135680908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-30-34
A. F. Iznak, E. V. Iznak, E. B. Rumyantseva, S. V. Sizov, I. V. Oleichik
The purpose of the study . Analysis of the features of EEG spectral parameters in patients with polymorphic and monomorphic subtypes of prolonged and chronic endogenous manic-delusional states (PEMDS). Materials and methods . A clinical-neurophysiological study was carried out in 76 female patients with monomorphic (group 1, 34 patients) and polymorphic (group 2, 42 patients) subtypes of PEMDS, identified based on clinical-dynamic analysis. Results . In the group 1, compared with the group 2, there were significantly lower values of the spectral power of the pre-treatment EEG in most EEG leads and frequency sub-bands, which reflect a significant deficit in the brain inhibitory systems. In the group 2, the EEG slowdown (in the delta-frequency sub-band) after treatment course, was significantly more pronounced in the frontal-anterotemporal-central cortical zones of the left hemisphere, reflecting a greater increase of the neurophysiological processes of inhibition in these brain areas under the influence of treatment, which leads to an improvement in the clinical condition of patients. Conclusions . The revealed differences in the brain functional activity organization may mediate the features of the clinical picture and therapeutic response in patients with polymorphic and monomorphic subtypes of PEMDS.
{"title":"EEG features in patients with different subtypes of prolonged and chronic endogenous manic-delusional states","authors":"A. F. Iznak, E. V. Iznak, E. B. Rumyantseva, S. V. Sizov, I. V. Oleichik","doi":"10.33667/2078-5631-2023-21-30-34","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-30-34","url":null,"abstract":"The purpose of the study . Analysis of the features of EEG spectral parameters in patients with polymorphic and monomorphic subtypes of prolonged and chronic endogenous manic-delusional states (PEMDS). Materials and methods . A clinical-neurophysiological study was carried out in 76 female patients with monomorphic (group 1, 34 patients) and polymorphic (group 2, 42 patients) subtypes of PEMDS, identified based on clinical-dynamic analysis. Results . In the group 1, compared with the group 2, there were significantly lower values of the spectral power of the pre-treatment EEG in most EEG leads and frequency sub-bands, which reflect a significant deficit in the brain inhibitory systems. In the group 2, the EEG slowdown (in the delta-frequency sub-band) after treatment course, was significantly more pronounced in the frontal-anterotemporal-central cortical zones of the left hemisphere, reflecting a greater increase of the neurophysiological processes of inhibition in these brain areas under the influence of treatment, which leads to an improvement in the clinical condition of patients. Conclusions . The revealed differences in the brain functional activity organization may mediate the features of the clinical picture and therapeutic response in patients with polymorphic and monomorphic subtypes of PEMDS.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"17 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135684522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-44-47
N. A. Pizov, N. V. Pizova
COVID-19 infection is associated with many different complications. The consequences of COVID-19 infection affect the quality of life and cause emotional distress. Rehabilitation activities for various groups of patients who have undergone COVID-19 are of great importance from several aspects. Each patient must be fully evaluated by the rehabilitation team. Together with the patient, the team should develop rehabilitation goals, taking into account the wishes of the patient. The direct impact of COVID-19, its consequences and comorbidities determine the medical rehabilitation plan. It is necessary to assess the state of physical, cognitive, emotional disorders. The purpose of the study . To determine the dynamics of anxiety-depressive and cognitive disorders in patients who have undergone COVID-19, using individual rehabilitation programs. Research methods . The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety-depressive disorders, and the Mini-Mental State Examination (MMSE) was used to identify cognitive impairment. A special rehabilitation scale for patient routing was used to assess the patient's condition, determine management and routing tactics. Conclusions . Individually tailored post-acute multidisciplinary rehabilitation is associated with clinical and functional improvements in patients who have experienced varying degrees of severity of COVID-19.
{"title":"Impact of rehabilitation measures on patients, who have undergone COVID-19, in post-acute period","authors":"N. A. Pizov, N. V. Pizova","doi":"10.33667/2078-5631-2023-21-44-47","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-44-47","url":null,"abstract":"COVID-19 infection is associated with many different complications. The consequences of COVID-19 infection affect the quality of life and cause emotional distress. Rehabilitation activities for various groups of patients who have undergone COVID-19 are of great importance from several aspects. Each patient must be fully evaluated by the rehabilitation team. Together with the patient, the team should develop rehabilitation goals, taking into account the wishes of the patient. The direct impact of COVID-19, its consequences and comorbidities determine the medical rehabilitation plan. It is necessary to assess the state of physical, cognitive, emotional disorders. The purpose of the study . To determine the dynamics of anxiety-depressive and cognitive disorders in patients who have undergone COVID-19, using individual rehabilitation programs. Research methods . The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety-depressive disorders, and the Mini-Mental State Examination (MMSE) was used to identify cognitive impairment. A special rehabilitation scale for patient routing was used to assess the patient's condition, determine management and routing tactics. Conclusions . Individually tailored post-acute multidisciplinary rehabilitation is associated with clinical and functional improvements in patients who have experienced varying degrees of severity of COVID-19.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"25 24","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135680898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-20-35-37
S. V. Proskokova, V. A. Voronetskaya, A. M. Enikeev, D. N. Kutuzov, A. E. Pirogov, K. M. Bogdanova
Relevance . The problem of traumatization of the oral mucosa with fixed orthodontic structures, especially at the initial stage of treatment, is one of the most urgent in orthodontics. Prolonged use of such structures often leads to adverse reactions from the oral mucosa in the form of chronic mechanical injury, burning, soreness, etc. The effectiveness of the use of alginate plates of the drug «Superlimf» as a correction of side effects from non-removable orthodontic equipment has been studied. Objective. To study the effectiveness of the use of the domestic cytokine preparation «Superlimf» in the form of alginate plates in the treatment of traumatic lesions of the oral mucosa that occur in patients at the stages of orthodontic treatment with fixed equipment. Materials and methods . The study included 35 people aged 18 to 25 years, of which 17 people used alginate plates «Superlimf» and 18 people – the control group – used orthodontic wax to protect the mucosa from injury. Results . The use of alginate plates «Superlimf» showed a reduction in the duration of the inflammatory process, a significant reduction in painful manifestations and swelling. Conclusion. The data obtained indicate the effectiveness of the drug «Superlimf» and allow us to recommend it for use in dental clinical practice.
{"title":"Evaluation of the effectiveness of immunomodulatory therapy in the treatment of traumatic lesions of the oral mucosa in orthodontic patients","authors":"S. V. Proskokova, V. A. Voronetskaya, A. M. Enikeev, D. N. Kutuzov, A. E. Pirogov, K. M. Bogdanova","doi":"10.33667/2078-5631-2023-20-35-37","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-20-35-37","url":null,"abstract":"Relevance . The problem of traumatization of the oral mucosa with fixed orthodontic structures, especially at the initial stage of treatment, is one of the most urgent in orthodontics. Prolonged use of such structures often leads to adverse reactions from the oral mucosa in the form of chronic mechanical injury, burning, soreness, etc. The effectiveness of the use of alginate plates of the drug «Superlimf» as a correction of side effects from non-removable orthodontic equipment has been studied. Objective. To study the effectiveness of the use of the domestic cytokine preparation «Superlimf» in the form of alginate plates in the treatment of traumatic lesions of the oral mucosa that occur in patients at the stages of orthodontic treatment with fixed equipment. Materials and methods . The study included 35 people aged 18 to 25 years, of which 17 people used alginate plates «Superlimf» and 18 people – the control group – used orthodontic wax to protect the mucosa from injury. Results . The use of alginate plates «Superlimf» showed a reduction in the duration of the inflammatory process, a significant reduction in painful manifestations and swelling. Conclusion. The data obtained indicate the effectiveness of the drug «Superlimf» and allow us to recommend it for use in dental clinical practice.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"24 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135679333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-54-60
O. I. Tsibirova, M. A. Privalova, M. G. Sokolova, A. Yu. Ulitin, S. А. Privalova, A. A. Tsibirov, M. Ya. Belikova
Moya-moya syndrome is a chronic cerebrovascular disease associated with narrowing of the arteries of the brain, manifested by headache, epileptic seizures, transient ischemic attack, leading to the development of ischemic or hemorrhagic stroke. To date, the main pathogenetic mechanisms of moya-moya syndrome have not yet been fully identified, but some studies have shown that an important component of the development of moya-moya is a genetic factor. However, if the issue of diagnosis of this syndrome can be considered solved – it is the use of neuroimaging methods (MRI, CT) with contrast of cerebral vessels, then the issue of treatment remains relevant. The article presents a clinical case of a patient with moya-moya syndrome with the transformation of an ischemic stroke into a hemorrhagic type.
{"title":"Clinical observation of patient with moya-moya syndrome complicated by transient ischemic attack followed by development of hemorrhagic stroke. Features of diagnosis and treatment","authors":"O. I. Tsibirova, M. A. Privalova, M. G. Sokolova, A. Yu. Ulitin, S. А. Privalova, A. A. Tsibirov, M. Ya. Belikova","doi":"10.33667/2078-5631-2023-21-54-60","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-54-60","url":null,"abstract":"Moya-moya syndrome is a chronic cerebrovascular disease associated with narrowing of the arteries of the brain, manifested by headache, epileptic seizures, transient ischemic attack, leading to the development of ischemic or hemorrhagic stroke. To date, the main pathogenetic mechanisms of moya-moya syndrome have not yet been fully identified, but some studies have shown that an important component of the development of moya-moya is a genetic factor. However, if the issue of diagnosis of this syndrome can be considered solved – it is the use of neuroimaging methods (MRI, CT) with contrast of cerebral vessels, then the issue of treatment remains relevant. The article presents a clinical case of a patient with moya-moya syndrome with the transformation of an ischemic stroke into a hemorrhagic type.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"39 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135680085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-35-38
L. G. Agasarov, B. S. Bazarova, T. V. Konchugova, T. V. Apkhanova
The work is devoted to the analysis of the mechanisms and evaluation of the effectiveness of various methods of topical use of essential oils in dorsopathies. Materials and methods . 90 patients (38 women and 52 men aged 40 to 75 years with exacerbation of dorsopathy at the lumbosacral level) were under observation. Along with neurological, psychological (using questionnaire methods) and electrophysiological analysis was performed, including thermography, rheovasography and ultrasound Doppler sonography of the vessels of the legs and feet. Three groups of 30 patients each were formed, in which standard treatment was performed. In addition to this, a mixture of essential oils was used in the first two groups. In the 1st group, with the use of this composition, massage of the lumbosacral zone was performed, in the 2nd group, the method of biopuncture was used, i. e., applying minimal doses of the mixture to the projection of reflexology points. In the 3rd control group, sesame oil was applied to the point area as a placebo. Results . In the course of the work, the effectiveness of both types of true use of essential oils was confirmed, significantly exceeding the control indicators in this regard. However, stable analgesia was achieved in the 2nd group significantly earlier than in the 1st: in a proportion close to this, the final intensity of pain sensations also decreased. On the other hand, in both groups of oil use, there was a comparable improvement in zonal vascular provision, confirmed electrophysiologically. Conclusions . During the follow-up evaluation, recurrences of dorsopathy in the control group were noted in a third of patients, whereas in the case of the use of essential oils, there were comparably fewer doses. Nevertheless, in these groups there are differences in the severity of recurring algias: in the 2nd group they increased slightly, while in others they increased to a greater extent. In addition, the data of rheovasograms testified in favor of greater stability of the results in the 2nd group. These differences can be explained by the cumulative effect inherent in the methods of reflexology and, in particular, biopuncture with essential oils.
{"title":"Point stimulation with essential oils in complex effect on lumbosacral dorsopathies","authors":"L. G. Agasarov, B. S. Bazarova, T. V. Konchugova, T. V. Apkhanova","doi":"10.33667/2078-5631-2023-21-35-38","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-35-38","url":null,"abstract":"The work is devoted to the analysis of the mechanisms and evaluation of the effectiveness of various methods of topical use of essential oils in dorsopathies. Materials and methods . 90 patients (38 women and 52 men aged 40 to 75 years with exacerbation of dorsopathy at the lumbosacral level) were under observation. Along with neurological, psychological (using questionnaire methods) and electrophysiological analysis was performed, including thermography, rheovasography and ultrasound Doppler sonography of the vessels of the legs and feet. Three groups of 30 patients each were formed, in which standard treatment was performed. In addition to this, a mixture of essential oils was used in the first two groups. In the 1st group, with the use of this composition, massage of the lumbosacral zone was performed, in the 2nd group, the method of biopuncture was used, i. e., applying minimal doses of the mixture to the projection of reflexology points. In the 3rd control group, sesame oil was applied to the point area as a placebo. Results . In the course of the work, the effectiveness of both types of true use of essential oils was confirmed, significantly exceeding the control indicators in this regard. However, stable analgesia was achieved in the 2nd group significantly earlier than in the 1st: in a proportion close to this, the final intensity of pain sensations also decreased. On the other hand, in both groups of oil use, there was a comparable improvement in zonal vascular provision, confirmed electrophysiologically. Conclusions . During the follow-up evaluation, recurrences of dorsopathy in the control group were noted in a third of patients, whereas in the case of the use of essential oils, there were comparably fewer doses. Nevertheless, in these groups there are differences in the severity of recurring algias: in the 2nd group they increased slightly, while in others they increased to a greater extent. In addition, the data of rheovasograms testified in favor of greater stability of the results in the 2nd group. These differences can be explained by the cumulative effect inherent in the methods of reflexology and, in particular, biopuncture with essential oils.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"28 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135681669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-21-48-53
P. I. Kudrina, A. N. Bogolepova, A. L. Ariev, S. S. Shadrina
Purpose of the study . Identification of cerebrorenal relationships in patients with chronic cerebral ischemia (CCI) of elderly and senile age. Material and methods . We studied 522 elderly and senile patients with stage I and II CCI living in the Republic of Sakha (Yakutia). Doppler ultrasound was the main method for studying cerebral hemodynamics in this work. Glomerular filtration rate (GFR), which is the most reliable integral measure of the functional state of the kidneys, was calculated using the CKD-EPI formula, which takes into account race, gender, age, and serum creatinine levels. Results . Between the value of the glomerular filtration rate and almost all ultrasonic indicators included in the analysis (except for the diameter of the right and left vertebral arteries and the linear velocity of blood flow in the vertebral artery on the right), weak and moderate negative correlations were found. A univariate analysis confirmed the existence of relationships between GFR, age, duration of CCI, and blood lipid parameters. Conclusions . The study revealed a statistical relationship between GFR and age, duration of CCI, lipid spectrum parameters, as well as with all 12 ultrasound parameters characterizing cerebral hemodynamics.
{"title":"Cerebrorenal connections in patients with chronic cerebral ischemia living in Republic of Sakha (Yakutia)","authors":"P. I. Kudrina, A. N. Bogolepova, A. L. Ariev, S. S. Shadrina","doi":"10.33667/2078-5631-2023-21-48-53","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-21-48-53","url":null,"abstract":"Purpose of the study . Identification of cerebrorenal relationships in patients with chronic cerebral ischemia (CCI) of elderly and senile age. Material and methods . We studied 522 elderly and senile patients with stage I and II CCI living in the Republic of Sakha (Yakutia). Doppler ultrasound was the main method for studying cerebral hemodynamics in this work. Glomerular filtration rate (GFR), which is the most reliable integral measure of the functional state of the kidneys, was calculated using the CKD-EPI formula, which takes into account race, gender, age, and serum creatinine levels. Results . Between the value of the glomerular filtration rate and almost all ultrasonic indicators included in the analysis (except for the diameter of the right and left vertebral arteries and the linear velocity of blood flow in the vertebral artery on the right), weak and moderate negative correlations were found. A univariate analysis confirmed the existence of relationships between GFR, age, duration of CCI, and blood lipid parameters. Conclusions . The study revealed a statistical relationship between GFR and age, duration of CCI, lipid spectrum parameters, as well as with all 12 ultrasound parameters characterizing cerebral hemodynamics.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135684808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.33667/2078-5631-2023-20-38-43
K. M. Salekh, A. A. Muraev, S. Y. Ivanov, A. A. Dolgalev, A. P. Bonartsev
Relevance. Simvastatin is a statin drug used for the clinical control of hypercholesterolemia. Over the past decades, there has been a steady increase in the number of studies on the possibilities of simvastatin, in many respects superior to the effect of lowering blood cholesterol levels. The use of simvastatin in the field of bone tissue regeneration, as well as its ability to reduce the inflammatory response, is being actively investigated. The purpose of the review: to consider modern ideas about simvastatin and to study its pleiotropic effects. Materials and methods. The analysis of scientific publications in the electronic databases eLIBRARY, PubMed and Google Scholar (articles, meta-analyses, systematic reviews) for the time interval from 2015 to 2022 was carried out. Materials containing information on the hypocholes-terolemic activity of simvastatin and its mechanism of action, the use of simvastatin in periodontal practice, as well as the osteoinductive effect of simvastatin and its use in bone engineering are included. Results. The review reviewed 83 articles, from which 53 articles were selected after reviewing the literature. Conclusion. Based on the analyzed data, it can be concluded that the effects of simvastatin are multifaceted. Its anti-inflammatory activity has been proven by inhibiting interleukins and inflammatory mediators, participation in bone tissue regeneration by gene expression and stimulation of osteoblast cell differentiation.
{"title":"The use of statin drugs in medical practice. Literature review","authors":"K. M. Salekh, A. A. Muraev, S. Y. Ivanov, A. A. Dolgalev, A. P. Bonartsev","doi":"10.33667/2078-5631-2023-20-38-43","DOIUrl":"https://doi.org/10.33667/2078-5631-2023-20-38-43","url":null,"abstract":"Relevance. Simvastatin is a statin drug used for the clinical control of hypercholesterolemia. Over the past decades, there has been a steady increase in the number of studies on the possibilities of simvastatin, in many respects superior to the effect of lowering blood cholesterol levels. The use of simvastatin in the field of bone tissue regeneration, as well as its ability to reduce the inflammatory response, is being actively investigated. The purpose of the review: to consider modern ideas about simvastatin and to study its pleiotropic effects. Materials and methods. The analysis of scientific publications in the electronic databases eLIBRARY, PubMed and Google Scholar (articles, meta-analyses, systematic reviews) for the time interval from 2015 to 2022 was carried out. Materials containing information on the hypocholes-terolemic activity of simvastatin and its mechanism of action, the use of simvastatin in periodontal practice, as well as the osteoinductive effect of simvastatin and its use in bone engineering are included. Results. The review reviewed 83 articles, from which 53 articles were selected after reviewing the literature. Conclusion. Based on the analyzed data, it can be concluded that the effects of simvastatin are multifaceted. Its anti-inflammatory activity has been proven by inhibiting interleukins and inflammatory mediators, participation in bone tissue regeneration by gene expression and stimulation of osteoblast cell differentiation.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"24 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135679332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：